Neogen | NEOG - Current Liabilities


Neogen reported $158.2M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Cerus USD 100.8M 12.37M Dec/2025
Danaher USD 8.1B 645M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Illumina USD 1.58B 12M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
Neogen USD 158.2M 7.6M Mar/2026
OraSure Technologies USD 44.08M 4.29M Mar/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Quidel USD 962.4M 3.7M Mar/2026
Rockwell Medical USD 10.95M 259K Jun/2025
STAAR Surgical USD 60.99M 7.51M Mar/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Utah Medical Products USD 3.5M 907K Mar/2026
Zoetis USD 2.06B 8M Jun/2026